Altria Group Inc. ( MO Quick Quote MO - Free Report) released first-quarter 2020 results, wherein both top and bottom lines increased year over year and beat the Zacks Consensus Estimate, backed by strength in both smokeable and oral tobacco product segments. However, management withdrew its 2020 earnings guidance owing to the uncertainty related to COVID-19. Quarter in Detail Adjusted earnings came in at $1.09 per share, which rose 18.5% year over year and beat the Zacks Consensus Estimate of 97 cents. The uptick can be attributed to increased adjusted operating companies income (OCI) in the smokeable and oral tobacco product segments along with a reduced number of outstanding shares. This was somewhat offset by a decrease in adjusted earnings from the company’s equity investment in AB InBev ( BUD Quick Quote BUD - Free Report) .
Net revenues advanced 13% year over year to $6,359 million. Revenues, after deducting excise taxes, grew 15% to $5,046 million. The consensus mark was $4,619 million. Revenues were backed by strength in the smokeless and oral tobacco product segments.
Gross profit in the quarter advanced 2.2% to $2,873 million from the prior-year quarter. Notably, reported OCI increased 4.7% to $2,400 million and operating income rose 4.4% to $2,336 million. Segment Details Smokeable Products: Net revenues in the category rose 13.6% year over year to $5,606 million due to greater shipment volumes and higher pricing. Revenues, net of excise taxes, grew 16% year over year to $4,328 million. Reported domestic cigarette shipment volumes climbed 6.1% year over year owing to trade inventory movements, consumers’ stockpiling amid the coronavirus-led crisis and calendar differences. This was partly offset by the cigarette industry’s rate of decline and retail share losses. During the quarter, the company’s total cigarette retail share declined 0.7 percentage point to 49.2%. On an adjusted basis, however, smokeable products’ domestic cigarette shipment volumes fell approximately 5% and total domestic cigarette industry volumes declined an estimated 3.5%. Meanwhile, Altria’s reported cigar shipment volumes rose 13.1%. Adjusted OCI in the segment improved 20.1% to $2,392 million, owing to better pricing and increased shipment volumes. Adjusted OCI margins rose 2 percentage points to 55.3%. Oral Tobacco Products: Net revenues in the segment improved 11.3% from the year-ago quarter to $601 million, driven by higher pricing and shipment volumes. Revenues, net of excise taxes, increased 12% to $570 million in the quarter. Domestic shipment volumes for the segment grew 2.8% due to the industry’s growth rate, calendar differences as well as retail and consumer stock hoarding amid the pandemic. This was partly offset by retail share losses and wholesale inventory trade movements. On an adjusted basis, however, oral tobacco products shipment volumes dipped an estimated 0.5%. Total oral tobacco products’ retail share went down 2.8 percentage points to 50.4%. Adjusted OCI rose 13.4% to $416 million, owing to improved pricing and shipment volumes, somewhat negated by elevated costs. Adjusted OCI margin expanded 0.9 percentage points to 73%. Wine: Net revenues fell 3.3% year on year to $146 million due to lower shipment volumes. This was somewhat compensated by improved pricing and mix. The segment’s revenues, net of excise taxes, dipped 2.7% to $142 million. Reported wine shipment volumes dropped 10.2% to about 1.7 million cases. Adjusted OCI in the category declined 13.3% to $13 million, resulting from escalated selling, general and administrative costs and reduced shipment volumes. Higher pricing and improved mix offered some respite. Adjusted OCI margin contracted 1.1 percentage points to 9.2%. Financial Updates Altria did not repurchase any shares during the first quarter and borrowed the entire $3 billion under its revolving credit facility. Additionally, management suspended the company’s share buyback plan of $1 billion, which had a balance of $500 million. Altria anticipates maintaining a higher cash balance in the coming quarters to protect its financial flexibility. Capital expenditures in 2020 are now envisioned in the range of $200-$250 million, down from the previous forecast of $225-$275 million. Other Developments & Guidance The company reopened its Richmond Manufacturing Center under improved safety measures. Consequently, all of the company’s manufacturing facilities are now operational amid the coronavirus outbreak. Till now, the company has not witnessed any material impacts of the outbreak on its supply chain or distribution systems. Also, it hasn’t experienced any material disruptions related to the government’s restrictions on consumer movements and business operations. However, given the uncertainty around the pandemic, management withdrew its 2020 adjusted earnings per share view. It also withdrew its compounded annual adjusted earnings growth guidance for 2020-2022. Price Performance Shares of this Zacks Rank #3 (Hold) company have lost 18.9% year to date compared with the industry’s decline of 12%. Looking for Consumer Staple Stocks? Check These The Hain Celestial Group, Inc. ( HAIN Quick Quote HAIN - Free Report) , with a Zacks Rank #1 (Strong Buy), has a trailing four-quarter positive earnings surprise of around 7%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here. Vector Group ( VGR Quick Quote VGR - Free Report) , with a Zacks Rank #2 (Buy), has a robust earnings surprise record. Today's Best Stocks from Zacks Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%. This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year. See their latest picks free >>